Ben Tseng

Why target apoptosis in cancer treatment?

Shailaja Kasibhatla, Ben Tseng · PubMed · 2003 · 354 citations

Medicine, Cancer Biology, Oncology +17

Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4<i>H</i>-chromenes, a novel series of anticancer agents

Henriette Gourdeau, Lorraine Leblond, Bettina A. Hamelin et al. · Molecular Cancer Therapeutics · 2004 · 289 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Methotrexate-induced misincorporation of uracil into DNA

Mehran Goulian, B. Bleile, Ben Tseng · Proceedings of the National Academy of Sciences · 1980 · 282 citations · Full text

Life Sciences, Genetics, Molecular Biology +9

Discovery of 4-Aryl-4<i>H</i>-chromenes as a New Series of Apoptosis Inducers Using a Cell- and Caspase-based High-Throughput Screening Assay. 1. Structure−Activity Relationships of the 4-Aryl Group

William Kemnitzer, John Drewe, Songchun Jiang et al. · Journal of Medicinal Chemistry · 2004 · 279 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure–activity relationships of the 7- and 5-, 6-, 8-positions

William Kemnitzer, Shailaja Kasibhatla, Songchun Jiang et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 273 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +15